Looking to trade an upshift in this penny pharma stock. Debt looks good and sales have been improving. Look to buy around the support level .021 and hold to .03. A stop loss at .019 . Risky share, but volatile price movements in a growth sector.
This share looks to be trading in an ascending channel, looks to be an accumulation underway. Marked are entry and exit points, and stop-loss. Sharing is trading much lower than previous highs. Company now has a good debt ratio, and carries a lot of tax loss credits making it appealing for merge/acquisition.
